Search tips
Search criteria 


Logo of skullbaseInstructions for AuthorsSubscribe to Skull BaseAbout Skull BaseEditorial BoardThieme Medical PublishingSkull Base An Interdisciplinary Approach ...
Skull Base. 2002 May; 12(2): 53–58.
PMCID: PMC1656918

Somatostatin Therapy for Glomus Tumors

A Report of Two Cases


Glomus tumors of the head and neck are benign vascular lesions that often provide dilemmas in management. The presence of somatostatin receptors on the tumor cell surface has facilitated an additional imaging technique in the form of radiolabeled octreotide scanning. The use of the somatostatin analogue, octreotide, also provides a therapeutic option for inoperable or recurrent tumors. We present two patients, one with a surgically inaccessible tumor that recurred after primary radiotherapy and one who underwent incomplete resection because of the tumor's proximity to the internal carotid artery. Neither tumor has shown further growth 5 and 3 years after treatment with octreotide, respectively.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Gulya AJ. The glomus tumor and its biology. Laryngoscope. 1993 Nov;103(11 Pt 2 Suppl 60):7–15. [PubMed]
  • Manolidis S, Shohet JA, Jackson CG, Glasscock ME., 3rd Malignant glomus tumors. Laryngoscope. 1999 Jan;109(1):30–34. [PubMed]
  • McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1994 Nov;120(11):1211–1216. [PubMed]
  • Reubi JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):27–35. [PubMed]
  • Lamberts SW, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 1991 Nov;12(4):450–482. [PubMed]
  • Reubi JC. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. Acta Endocrinol (Copenh) 1985 May;109(1):108–114. [PubMed]
  • Setyono-Han B, Henkelman MS, Foekens JA, Klijn GM. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 1987 Mar 15;47(6):1566–1570. [PubMed]
  • Mascardo RN, Sherline P. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. Endocrinology. 1982 Oct;111(4):1394–1396. [PubMed]
  • Lamberts SW, Reubi JC, Uiterlinden P, Zuiderwijk J, van den Werff P, van Hal P. Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. Endocrinology. 1986 Jun;118(6):2188–2194. [PubMed]
  • Schally AV. Oncological applications of somatostatin analogues. Cancer Res. 1988 Dec 15;48(24 Pt 1):6977–6985. [PubMed]
  • Kau R, Arnold W. Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck. Acta Otolaryngol. 1996 Mar;116(2):345–349. [PubMed]
  • Telischi FF, Bustillo A, Whiteman ML, Serafini AN, Reisberg MJ, Gomez-Marin O, Civantos FJ, Balkany TJ. Octreotide scintigraphy for the detection of paragangliomas. Otolaryngol Head Neck Surg. 2000 Mar;122(3):358–362. [PubMed]
  • Moe KS, Li D, Linder TE, Schmid S, Fisch U. An update on the surgical treatment of temporal bone paraganglioma. Skull Base Surg. 1999;9(3):185–194. [PMC free article] [PubMed]
  • Simko TG, Griffin TW, Gerdes AJ, Parker RG, Tesh DW, Taylor W, Blasko JC. The role of radiation therapy in the treatment of glomus jugulare tumors. Cancer. 1978 Jul;42(1):104–106. [PubMed]
  • Hurst RD, Modlin IM. Use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor-bearing tumors. Digestion. 1993;54 (Suppl 1):88–91. [PubMed]

Articles from Skull Base are provided here courtesy of Thieme Medical Publishers